Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.
about
Tuberculosis and HIV co-infectionIL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaquesCombination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infectionAssociation of HLA-alleles with the immune regulation of chronic viral infectionsTissue-resident memory T cellsSystems biology applied to vaccine and immunotherapy developmentDistinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse modelThe role of interleukin-21 in HIV infectionThe enduring tale of T cells in HIV immunopathogenesisSAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral functionGagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivoBroad and potent neutralization of HIV-1 by a gp41-specific human antibodyCellular immune responses and susceptibility to HIV-1 superinfection: a case-control studyCD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21Inhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressorsLong-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccineEfficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cellsImmune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?Vaccine design for CD8 T lymphocyte responsesPushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses.HIV-1 Vaccine Trials: Evolving Concepts and DesignsCD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesisTransient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllersHIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccineBreadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variablesTissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustionUnexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replicationPredominance of weakly cytotoxic, T-betLowEomesNeg CD8+ T-cells in human gastrointestinal mucosa: implications for HIV infection.Timing of immune escape linked to success or failure of vaccination.Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progressionProliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression.Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers.Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 ControllerA low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge.Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination
P2860
Q21131403-AA8ABF85-CB84-40F5-B2BE-7F81DAC89A9AQ24630281-542B4A23-D68D-46E3-AC7E-805855593A44Q26748624-594C7549-9AB3-489E-A9F9-51250CBCFC3EQ26823033-91B6EC81-633B-43E8-9128-269492A27AC8Q26829804-70028174-FED9-4742-B4F5-0D24EFC52C32Q26830374-F53FDB55-7ED3-422C-A6CB-5EE7540F8122Q27003380-646BF736-B609-46F4-9369-181CFA4710D6Q27004704-E926B5CE-8D56-4D0F-AB61-C0DF0F515006Q27025707-DD432CC6-83CE-4424-B6E6-E428C006793EQ27321665-83C55A0A-49A0-47D0-9C9B-427C47C11963Q27323727-72B11C62-E9A1-4802-B5E6-F6F29E7AA7CCQ27324128-5887ED40-D655-44A3-B837-2457AC9B05B2Q27675131-FCD6F821-A061-4EBF-A71A-1E0EB3920005Q28256438-20AFDFEB-3A17-444D-8F46-495DA70AAF0FQ28307312-EDB3417E-9B34-46C5-97FE-4B6E2CFD1F5EQ28710569-D4A14FDB-2012-435C-8216-F2C26F8F2E93Q28743435-8B9926FB-7D11-4430-BD9C-FD7C9ADB2E70Q28748976-7C4666FD-76FD-4971-8FD5-A87681DAE79BQ30362489-624B8FA4-0827-4CF5-A3DE-631830AEE2E7Q30411492-B21C2E28-63B6-4E16-9286-9811EBB99967Q30416916-4C922748-BBE9-4ABB-9107-0954CB1F65FFQ30425520-18DF3C88-20B9-4834-8C6A-37EC05330A7DQ30432007-940732E3-920E-4F43-9DBF-4F2D6F068BB3Q33443913-B5F7B745-2E9F-42EE-825E-6F94E057BF8DQ33535905-60420AB2-2AE2-41C2-8D97-44DE86F3C16CQ33594461-25CB8EB7-2DC3-4664-AF59-4A045C3F23DFQ33611645-A8BE09B6-D2C6-4893-B846-C80FD085FE00Q33614476-34266D99-B974-461B-8B17-D925687928EFQ33614495-B1D4E2F8-511F-4F2B-BFB1-088D46F780AAQ33614649-311DF180-F279-47C0-BC1D-8D6A9640C339Q33631183-C24AF730-C61F-4840-A310-64220BE6ABEAQ33653526-84203034-4108-4EEF-B46A-7A18D82976C2Q33700493-DEE7140D-92F1-480D-BF66-C3C67630B195Q33712891-8871EC49-B6C4-4394-B2C7-F4480B4FBECBQ33769360-D4AFC50C-41ED-4ABD-BC08-1514057398FDQ33805995-0D4C0FB9-1BB7-458B-8103-F460D7E1A592Q33809708-2453CDEE-B673-4BF9-AED7-B43E633149ABQ33815728-F35ED302-DF3B-411E-A300-FAC498FC71CEQ33826671-B2B1F861-E5B9-4FE1-9073-574B6D2E39BFQ33826974-9D54D1F1-9FE2-42B5-87DA-E109BEDFF0A5
P2860
Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lytic granule loading of CD8+ ...... ssociated with immune control.
@en
Lytic granule loading of CD8+ ...... ssociated with immune control.
@nl
type
label
Lytic granule loading of CD8+ ...... ssociated with immune control.
@en
Lytic granule loading of CD8+ ...... ssociated with immune control.
@nl
prefLabel
Lytic granule loading of CD8+ ...... ssociated with immune control.
@en
Lytic granule loading of CD8+ ...... ssociated with immune control.
@nl
P2093
P2860
P50
P1433
P1476
Lytic granule loading of CD8+ ...... ssociated with immune control.
@en
P2093
Akira Komoriya
Amy M Berkley
Ann P Wiegand
Beverly Z Packard
Cassandra Royce
Catherine Rehm
Christine M Osborne
Dean A Follman
Frank Maldarelli
Gregg Roby
P2860
P304
P356
10.1016/J.IMMUNI.2008.10.010
P407
P577
2008-12-08T00:00:00Z